These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Structure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic Properties. James KD, Laudeman CP, Malkar NB, Krishnan R, Polowy K. Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27919891 [Abstract] [Full Text] [Related]
5. CD101: a novel long-acting echinocandin. Zhao Y, Perez WB, Jiménez-Ortigosa C, Hough G, Locke JB, Ong V, Bartizal K, Perlin DS. Cell Microbiol; 2016 Sep; 18(9):1308-16. PubMed ID: 27354115 [Abstract] [Full Text] [Related]
6. In vitro potency and fungicidal activity of CD101, a novel echinocandin, against recent clinical isolates of Candida spp. Hall D, Bonifas R, Stapert L, Thwaites M, Shinabarger DL, Pillar CM. Diagn Microbiol Infect Dis; 2017 Nov; 89(3):205-211. PubMed ID: 28826987 [Abstract] [Full Text] [Related]
8. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis. Boikov DA, Locke JB, James KD, Bartizal K, Sobel JD. J Antimicrob Chemother; 2017 May 01; 72(5):1355-1358. PubMed ID: 28158577 [Abstract] [Full Text] [Related]
9. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates. Pfaller MA, Messer SA, Rhomberg PR, Jones RN, Castanheira M. J Antimicrob Chemother; 2016 Oct 01; 71(10):2868-73. PubMed ID: 27287236 [Abstract] [Full Text] [Related]
10. In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation. Prażyńska M, Bogiel T, Gospodarek-Komkowska E. Folia Microbiol (Praha); 2018 Mar 01; 63(2):209-216. PubMed ID: 28983822 [Abstract] [Full Text] [Related]
14. The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms. Bink A, Kucharíková S, Neirinck B, Vleugels J, Van Dijck P, Cammue BP, Thevissen K. J Infect Dis; 2012 Dec 01; 206(11):1790-7. PubMed ID: 22984120 [Abstract] [Full Text] [Related]
16. Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris. Berkow EL, Lockhart SR. Diagn Microbiol Infect Dis; 2018 Mar 01; 90(3):196-197. PubMed ID: 29307565 [Abstract] [Full Text] [Related]
17. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model. El-Azizi M, Farag N, Khardori N. Ann Clin Microbiol Antimicrob; 2015 Apr 03; 14():21. PubMed ID: 25885806 [Abstract] [Full Text] [Related]
18. Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model. Kucharíková S, Sharma N, Spriet I, Maertens J, Van Dijck P, Lagrou K. Antimicrob Agents Chemother; 2013 May 03; 57(5):2365-8. PubMed ID: 23403433 [Abstract] [Full Text] [Related]
19. Activity of Allyl Isothiocyanate and Its Synergy with Fluconazole against Candida albicans Biofilms. Raut JS, Bansode BS, Jadhav AK, Karuppayil SM. J Microbiol Biotechnol; 2017 Apr 28; 27(4):685-693. PubMed ID: 28138121 [Abstract] [Full Text] [Related]
20. Assessment and Optimizations of Candida albicans In Vitro Biofilm Assays. Lohse MB, Gulati M, Valle Arevalo A, Fishburn A, Johnson AD, Nobile CJ. Antimicrob Agents Chemother; 2017 May 28; 61(5):. PubMed ID: 28289028 [Abstract] [Full Text] [Related] Page: [Next] [New Search]